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and nerve growth in osteoarthritic human menisci, providing a mechanism
for the genesis of pain in knee OA.
Methods: Cases from whom menisci were obtained post mortem (PM) were
screened based on displaying either high or low macroscopic tibiofemoral
chondropathy scores (possible range 0 to 400) as a measure of the presence
and degree of OA. Forty cases (20 per group) were selected for study of
meniscal vascularity and 16 cases (8 per group) for study of meniscal in-
nervation. Antibodies directed against alpha-actin (vascular smooth muscle
and pericytes) and calcitonin gene-related peptide (CGRP) (sensory nerves)
were used to localise blood vessels and nerves by immunohistochemistry.
Computer-assisted image analysis was used to compare vascular densities
and nerve growth between menisci from high and low chondropathy
groups. Vascular density was measured as the percentage of tissue section
area occupied by alpha-actin immunoreactivity (1) in synovium adjacent
to inner meniscal region (two ﬁelds of highest vascular densities), (2) in
all ﬁelds along the sagital ﬁbrocartilage junction between inner and outer
meniscal regions, and (3) within 8 consecutive ﬁelds along the entire trans-
verse midline from the inner tip to the periphery. Inter-group comparison
of vascular densities within each ﬁeld along the midline was used as a
measure of vascular distribution. Nerve densities were measured as the
number of nerve proﬁles within 6 most densely innervated ﬁelds of view in
the outer region of the meniscus. Each individual ﬁeld of view comprised
an area of 1.68mm2 for the vascular study and 16800μm2 for the nerve
growth study. Comparison between groups was made using Mann Whitney
U test and data are presented as median [Interquartile Range (IQR)].
Results: Patients in the high chondropathy group had chondropathy scores
of 203 (198 to 245) or 199 (181 to 240) and those in low chondropathy
group had scores of 24 (15 to 27) or 33 (19 to 46), for the vascular or nerve
studies respectively (both P<0.0005). Vascular densities were greater in
the high than in the low chondropathy group both in the synovium [3.8%
(2.6 to 5.2), 2.0% (1.4 to 2.9), P=0.002] and at the ﬁbrocartilage junction
[2.3% (1.7 to 3.1), 1.1% (0.8 to 1.9), P=0.003]. The outer meniscal region was
more vascular than the inner region, with an abrupt drop in vascularity
in the fourth ﬁeld along the midline from the tip of the menisci, which
corresponded to the region of the ﬁbrocartilage junction. Vascular densities
in the 4th ﬁeld were greater in the high than in the low chondropathy
group [1.0% (0.3 to 1.5), 0.3% (0.0 to 0.8), P=0.015] indicating a greater
degree of vascular penetration in the high chondropathy group. Menisci
from the high chondropathy group had greater number of perivascular
sensory nerve proﬁles in the outer region [144 nerve proﬁles/mm2 (134 to
189)] compared to menisci from the low chondropathy group [119 nerve
proﬁles/mm2 (104 to 1144), P=0.049].
Conclusions: Vascular penetration into the meniscus is increased in OA
and is associated with increased sensory nerve growth. Vascularisation and
the associated innervation in menisci may contribute to pain in knee OA.
Acknowledgements: We are grateful to AstraZeneca for ﬁnancial support
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Introduction: Onset and progression of osteoarthritis (OA) are associated
with obesity. Since not only knee OA but also hand OA is associated
with obesity, systemic metabolic factors next to mechanical factors might
inﬂuence this process. Recent studies showed that adipose tissue is not
only able to secrete adipokines but also cytokines such as IL-1beta and IL-6.
In this study, we investigated whether infrapatellar fat pad (IPFP) is able to
inﬂuence cartilage biology and contribute to the onset of OA.
Methods: Explants of Hoffa’s fat pad obtained during total knee replace-
ment of 29 OA patients were cultured separately in medium for 24
hours in a concentration of 50 mg/mL resulting in 29 different batches
of fat conditioned medium (FCM). Pro-inﬂammatory (IL-1β, IL-6, IL-12)
and anti-inﬂammatory cytokines (IL-10) and growth factors (FGF2 and
PAI1) content (Luminex) of the FCM were measured and the presence
of CD68+ (macrophages), CD86+ (classically activated macrophages) and
CD206+ (alternatively activated macrophages) cells in the explants of IPFP
(immunohistochemistry) were determined.
Explants of healthy cartilage were cultured in FCM (1:1 with fresh medium)
for 48 hours. We evaluated Nitric Oxide (NO) production and glycosamino-
glycan (GAG) release by the cartilage, gene expression of MMP1, MMP13,
ADAMTS4, ADAMTS5 and COMP in the cartilage.
Results: All cytokines were measurable in the 29 batches of FCM. High
numbers of CD68+ cells and CD206+ cells were present in the IPFPs, but
large variety was seen between the patients. Samples of Hoffa’s fat pad
with high numbers of CD68+ cells seemed to produce more PAI1 than
samples with low numbers of CD68+ cells. When high numbers of CD206+
cells were present, a trend towards high levels of FGF2 was seen in the
FCM. No association was found between CD86+ cells and production of
cytokines. Culturing cartilage in FCM resulted in lower NO production and
GAG release than the control condition. MMP1 gene expression was also
lower in response to the FCM, whereas MMP13, ADAMTS4 and ADAMTS5
remained unchanged. COMP gene expression increased in response to FCM.
Figure 1. Effect of fat conditioned medium (n=29) relative to the untreated control (set
at 0, n=9) on NO production, GAG release, and gene expression of MMP1, and COMP.
*Indicates a signiﬁcant difference from the control (p < 0.02), **Indicates a signiﬁcant
difference from the control (p<0.002).
Discussion: Medium conditioned by infrapatellar fat pad from late os-
teoarthritis patients had mainly anabolic effects on cartilage. High numbers
of macrophages (CD68+ cells) and alternatively activated macrophages
(CD206+ cells) were present in the IPFPs used for making the fat con-
ditioned medium. These cells might have contributed to the production
of anti-inﬂammatory cytokines and growth factors and thus the an-
abolic/repair effect seen on cartilage.
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Purpose: Joint instability caused by anterior cruciate ligament (ACL) de-
ﬁciency is a known risk factor for early onset of osteoarthritis (OA), but
aging-related changes in the ACL and their relationship to changes in
articular cartilage and onset of OA are not well characterized. The purpose
of this study was to correlate histological and cellular changes in ACL with
cartilage lesion patterns and severity in human knee joints at autopsy.
Methods: Human knee joints were obtained at autopsy (n=95; age 24-92
yr), and cartilage and ACL were graded macroscopically and histologically.
Macroscopic grading of all cartilages was performed using a modiﬁed
Outerbridge scoring system and the ICRS knee map. The macroscopic
appearance of ACL degeneration was classiﬁed as normal, abnormal and
ruptured (Alline et al 2001 Acta Orthop Scand). For histology ACLs were
resected at the insertions sites on the femur and tibia. Approximately 1cm
thick transverse and longitudinal sections were harvested from midsub-
stance and femur attachment side where ACL tears frequently occur. ACL
sections were stained with hematoxylin and eosin, and graded histologi-
cally as follows; 1) orientation of collagen ﬁbers; 2) formation of new blood
vessels and inﬂammatory cell inﬁltrates; 3) change in the size of fascicles.
Both saggital and axial sections of each ACL were scored. ACL inﬂammation
was analyzed separately as the extent of synovial hyperplasia surrounding
the ACL, and changes within the ligament itself. Immunohistochemistry
and western blotting was also performed with antibodies to MMP-3 and
CD45 antibody.
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Results: On macroscopic examination 47 knees had normal, 36 abnormal
and 12 ruptured ACLs. ACL histological scores for collagen degeneration
and the number of blood vessels increased with aging. We compared
with summed cartilage scores to determine the relationship between ACL
and cartilage degeneration. There was a positive correlation between ACL
scores and total, trochlear and medial but not with lateral cartilage scores.
Increased MMP-3 and CD45 expression in ACLs correlated with ACL de-
generation score especially in the gaps between fascicles and in the cell
inﬁltrates around blood vessels.
Conclusions: ACL degeneration correlates with cartilage degeneration,
especially in the medial compartment of the knee joint. This suggests
that ACL deﬁciencies contribute not only to posttraumatic OA but also to
aging-related development of cartilage degradation and OA pathogenesis.
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Purpose: To test the hypothesis that in vivo transgene expression mediated
by adeno-associated virus serotype 2 (AAV2) following single intra-articular
injection of AAV is: (1) localized to the injected joint, (2) persists through
one year after injection, and (3) can be externally controlled.
Methods: Nine male Sprague-Dawley (SD) rats received AAV2-CMV-GFP
and AAV2-CMV-Luciferase (Luc) into their right and left knees, respectively.
Luciferase expression was evaluated over a 1-year period using the IVIS®
Imaging System (Xenogen). After sacriﬁce, tissues within the joint were
analyzed by ﬂuorescence stereomicroscopy to detect GFP+ cells. To study
the ability to control AAV transgene expression in the rat knee joint, an
additional ﬁve male SD rats received AAV2-tetracycline response element
(TRE)-Luc and AAV2-CMV-transcriptional transactivator into the right knee,
and AAV2-CMV-Luc into the left knee. To induce expression of luciferase, 2
mg/ml doxycycline (Dox) was added to the drinking water, and rats were
imaged twice a week as described above.
Results: Luciferase expression was detectable in all rats post-injection.
Long-term rats showed continued and stable luciferase expression through
1 year. GFP+ cells were mainly found in the intra-articular soft tissues
surrounding the articular cartilage, with rare GFP+ chondrocytes. For the
joints injected with inducible AAV-TRE-Luc, gene expression was upregu-
lated (p<0.05) after addition of Dox, and downregulated (p<0.05) following
removal of Dox.
Conclusions: Longitudinal in vivo results show persistent and stable
AAV-mediated gene expression through one year following a single intra-
articular injection. The use of inducible TRE promoter allows the feasibility
to control in vivo transgene expression in the rat knee joint. These results
suggest that AAV is a potential therapeutic approach to deliver growth
factors in the knee joint persistently in a time-controlled manner. The
rare occurrence of GFP+ cells in intact articular cartilage indicates that
more studies on AAV delivery to damaged articular cartilage, which can
progress to osteoarthritis, are needed. This continued characterization of
the length, location and ability to control transgene expression following
intra-articular injection of AAV will help to better tailor gene therapy
for articular cartilage repair, which may delay or prevent the onset of
osteoarthritis.
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Purpose: Tendon lesion is one of the most frequent pathology in sports and
by physical workers. This pathology often becomes chronic. For this reason,
it is of interest to develop new treatments. Injection of platelet-rich plasma
(PRP) seems to be a promising one by releasing growth factors (GF) locally.
Among all the GF released by activated platelets, the vascular endothelial
growth factor-A (VEGF-A) is known to induce positive effects on vascular
function and angiogenesis, and could be implicated in the healing process
of tendons. Recently, a novel VEGF-A isoform was identiﬁed, the VEGF-111,
a biologically active and proteolysis-resistant VEGF-A isoform, also known
to present beneﬁcial effects on ischemic diseases. This prompted us to
evaluate whether VEFF-111 would have a therapeutic interest within the
framework of the tendon pathology.
Methods: 60 Rats were divided into 2 groups: A: control (no injection), B:
VEGF-111 treatment. A 5mm defect was surgically induced in rat Achilles
tendon after resection of plantaris tendon. Rats received a local injection of
VEGF-111 (100ng) in situ after the surgery and were placed in their cages
without immobilization. After 5, 15 and 30 days, the traumatized Achilles
tendons of 10 rats of both groups were removed and dissected during their
healing process. Immediately after sampling, tendons were submitted to
a biomechanical tensile test up to rupture, using a “Cryo-jaw”. Rats were
then euthanized.
Statistical analyses were made with an ANOVA. Values are signiﬁcant when
p-value is below 0.05.
Results: Our results shown that the developed force necessary to induce
tendon rupture during biomechanical tensile test was greater for tendons
which had received an injection of 100ng of VEGF-111. These results were
already noticed from day 5 onwards. The ratio between force and weight
increased with time in both groups, but this ratio was greater for tendons
which had been submitted to an injection of VEGF111. The surface area of
the section of the tendons increased between 5 and 15 days followed by
a stabilization. After 30 days, sections in both groups were similar. Thus,
the constraint was similar after 5 and 15 days but was better for VEGF111
group after one month.
Conclusions: This experimentation has shown that a 100ng injection of
VEGF-111 stimulated tendon healing process as suggested by the increased
force needed to break tendons during its healing process and the increased
of constraint in comparison with the control group. Other experimentations
with different concentration of VEGF111 are now in process.
Acknowledgement: This experimentation was partially ﬁnanced by “Stan-
dard de Liège 2007” and “Lejeune-Lechien 2008” grants.
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Introduction: Meniscal degeneration is a signiﬁcant prognostic factor in
progressive cartilage loss in symptomatic knee osteoarthritis (OA). Despite
this, relatively little is known about the mechanisms of meniscal degener-
ation and whether this differs from articular cartilage (AC). The meniscus
has distinct zones, the inner ∼1/3rd being avascular and ﬁbrocartilaginous
while the outer region is vascular and more ﬁbrous. Recent studies have
examined meniscal degeneration in vitro using explant cultures but have
not directly compared the inner versus outer zones and with AC.
Methods: Ovine AC and inner and outer zone meniscal explants were
dissected from the same joints, and cultured separately for 4 days in
serum free media ± IL-1α (10ng/ml) or TNFα (100ng/ml); n≥6 for all treat-
ments. Matrix metabolism and enzyme activity were assessed by sulphated
glycosaminoglycan (GAG) and collagen (hydroxyproline) release, qRT-PCR
(aggrecan; collagen I & II; MMP-1, -2, -3, -9, -13, & -14; TIMP-1 & -3),
aggrecan neoepitope Western blotting, gelatin zymography, and MMP-13
substrate assay. Only differences where p < 0.05 are reported.
Results: Both meniscal zones had higher GAG release (% total) than AC
in control and cytokine treated cultures. Inner meniscus was similar to
AC with a signiﬁcant increase in GAG release after both cytokines; outer
meniscus showed less response and only to IL-1α. The outer meniscus
was unique in releasing signiﬁcant collagen following cytokine stimu-
lation. Aggrecan loss in control meniscal cultures was associated with
ADAMTS-cleavage (increased NITEGE compared to ex-vivo). IL-1α- and
TNFα-stimulated aggrecan loss in AC and inner meniscus was associated
with increased NITEGE, while cleavage by MMPs (increased DIPEN) pre-
dominated in outer meniscus. Expression of aggrecan, collagen I & II
ex-vivo reﬂected tissue compositions. Aggrecan and collagen mRNA were
decreased in all tissues by IL-1α and TNFα. ADAMTS-5 mRNA was increased
compared with ex-vivo in control meniscal but not AC cultures. IL-1α and
TNFα increased ADAMTS-4 & ADAMTS-5 expression in the meniscus more
than AC, with ADAMTS-4 more responsive to IL-1α and ADAMTS-5 to TNF.
MMP-1, -3, -9, -13 & -14 expression increased in both meniscal zones with
IL-1α and TNFα, while MMP-2 only increased in the outer zone. In contrast,
only MMP-1 and -3 were signiﬁcantly increased by cytokines in AC, and
